| Antiviral drug with low potential for drug-drug interactions; administered via intravenous infusion |
| Improves time to recovery in hospitalized patients |
| May have a mortality benefit in hospitalized patients with minimal oxygen requirements |
| Reduces the risk of hospitalization or death in outpatients at high risk for disease progression |
| Generally well tolerated |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.